Alto NeuroscienceANRO
13F holders, Q1 2024 (March 31)52holders
3famous investors
$15.35avg. 13F price*
At the end of Q1 2024, 52 institutions reported holding Alto Neuroscience Inc. (ANRO) in their 13F filings. The largest holders were Alpha Wave Global, LP ($56.9M), FMR LLC ($36.1M) and Ra Capital Management, L.P. ($21.3M). 3 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Alto Neuroscience Inc.
- CUSIP
- 02157Q109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 53 | $244.8M |
| Exits | 0 | $0 |
Ownership 52 holders
| Alpha Wave Global, LP | 17.30% | New | 3,707,757 | $56.9M |
| FMR LLC | 0.00% | New | 2,349,916 | $36.1M |
| Ra Capital Management, L.P. | 0.27% | New | 1,385,491 | $21.3M |
| Point72 Asset Management | 0.05% | New | 1,125,000 | $17.3M |
| 72 Investment Holdings, LLC | 15.28% | New | 667,778 | $10.3M |
| T. Rowe Price Associates Inc. | 0.00% | New | 637,604 | $9.8M |
| Franklin Resources Inc. | 0.00% | New | 625,012 | $9.6M |
| ExodusPoint Capital Management, LP | 0.12% | New | 606,730 | $9.3M |
| Deep Track Capital, LP | 0.26% | New | 600,000 | $9.2M |
| Vanguard Group Inc. | 0.00% | New | 536,332 | $8.2M |
| Jennison Associates LLC | 0.00% | New | 458,599 | $7.0M |
| Philadelphia Financial Management of San Francisco, LLC | 1.40% | New | 435,489 | $6.7M |
| Artal Group S.A. | 0.14% | New | 350,000 | $5.4M |
| Board of Trustees of The Leland Stanford Junior University | 0.46% | New | 344,015 | $5.3M |
| AWM Investment Company, Inc. | 0.60% | New | 299,147 | $4.6M |
| Vestal Point Capital, LP | 0.32% | New | 250,000 | $3.8M |
| Citadel Advisors | 0.00% | New | 173,648 | $2.7M |
| Valor Management LLC | 0.50% | New | 157,038 | $2.4M |
| BlackRock Inc. | 0.00% | New | 141,568 | $2.2M |
| Woodline Partners LP | 0.02% | New | 125,000 | $1.9M |
| Millennium Management | 0.00% | New | 119,216 | $1.8M |
| Fred Alger Management, LLC | 0.01% | New | 118,016 | $1.8M |
| Geode Capital Management, LLC | 0.00% | New | 86,141 | $1.3M |
| BIT Capital GmbH | 0.11% | New | 79,562 | $1.2M |
| Zimmer Partners, LP | 0.03% | New | 75,000 | $1.2M |
| Walleye Capital LLC | 0.01% | New | 50,000 | $768K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 45,031 | $691K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 35,670 | $548K |
| Citigroup Inc. | 0.00% | New | 33,842 | $519K |
| Jane Street Group, LLC | 0.00% | New | 33,059 | $507K |
| Sphera Funds Management LTD. | 0.08% | New | 30,500 | $468K |
| Norges Bank | 0.00% | New | 28,873 | $443K |
| Squarepoint Ops LLC | 0.00% | New | 28,369 | $435K |
| Lighthouse Investment Partners, LLC | 0.03% | New | 27,823 | $427K |
| State Street Corp. | 0.00% | New | 25,400 | $390K |
| JPMorgan Chase & Co. | 0.00% | New | 24,997 | $384K |
| Marshall Wace, LLP | 0.00% | New | 21,293 | $327K |
| Northern Trust Corp. | 0.00% | New | 16,387 | $252K |
| Diametric Capital, LP | 0.14% | New | 16,200 | $249K |
| Morgan Stanley | 0.00% | New | 13,285 | $204K |
| Bank of America Corp. | 0.00% | New | 12,901 | $198K |
| DAFNA Capital Management LLC | 0.04% | New | 10,000 | $154K |
| Alyeska Investment Group, L.P. | 0.00% | New | 10,000 | $154K |
| Blair William & Co. | 0.00% | New | 10,000 | $154K |
| Federated Hermes, Inc. | 0.00% | New | 9,000 | $138K |
| Barclays PLC | 0.00% | New | 5,904 | $91K |
| Qube Research & Technologies Ltd | 0.00% | New | 4,336 | $67K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,046 | $16K |
| UBS Group AG | 0.00% | New | 867 | $13K |
| Wolff Wiese Magana LLC | 0.01% | New | 730 | $11K |
| Wells Fargo & Company | 0.00% | New | 65 | $998 |
| Macquarie Group Ltd. | 0.00% | New | 473 | $7 |
"% of holder's portfolio" is ANRO's weight in each manager's 13F, not the share of Alto Neuroscience Inc. the manager owns.